Xinying Xue

8PUBLICATIONS
11CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsZoology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 26, 2026
Potential therapeutic targets for Cryptococcus.

Jing Liu, Xiaozhuo Dong, Yemei Huang

|Nov 13, 2025
Continuing immune checkpoint inhibitors after pseudoprogression improves survival in lung cancer patients: a systematic review and meta-analysis.

Aiben Huang, Mei Xie, Chongchong Wu

|Jul 12, 2025
A Lymphocyte Subset-Based Prediction Model for Refractory Community-Acquired Pneumonia in Immunocompetent Patients.

Jingyuan Zhang, Xinyu Hu, Ailifeila Aili

|Oct 17, 2024
Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer.

Jie Yao, Xuwen Lin, Xin Zhang

|Mar 07, 2024
Immune-related adverse events in non-small cell lung cancer: Occurrence, mechanisms and therapeutic strategies.

Xuwen Lin, Mei Xie, Jie Yao

|Oct 31, 2023
Virulence profiling of Cryptococcus gattii isolates in China: insights from a multi-center study.

Xuelei Zang, Weixin Ke, Yemei Huang

Pageof 2

Frequent Collaborators

3 joint publications

Xuelei Zang

1 joint publications

Youqiong Ye

1 joint publications

Lixia Diao

1 joint publications

Steven H Lin